Speaker illustration

Doctor Alexey Tarasov

National Research Center for Preventive Medicine, Moscow (Russian Federation)

Comparison of the efficacy and safety of injectable propafenone and amiodarone for elimination of paroxysmal atrial fibrillation in patients without organic heart disease.

Event: EHRA 2019

Topic: Antiarrhythmic Drug Treatment

Session: Arrhythmias

Thumbnail

Comparison of antiarrhythmic drugs clinical effect during early post procedural period after atrial fibrillation ablation.

Event: ESC CONGRESS 2017

Topic: Antiarrhythmic drugs

Session: Drug treatment

Thumbnail

Comparison of propafenone and sotalol effectiveness in prevention of atrial tachyarrhythmias in early postablation period of atrial fibrillation

Event: ESC CONGRESS 2016

Topic: Antiarrhythmic drugs

Session: Miscellaneous in arrhythmia

Thumbnail

This platform is supported by

logo Novo Nordisk